Low-dose of aspirin is likely to increase survival chances in cancer patients

Low-dose of aspirin is likely to increase survival chances in cancer patients

"Our review, based on the available evidence, suggests that low-dose aspirin taken by patients with bowel, breast or prostate cancer, in addition to other treatments, is associated with a reduction in deaths of about 15-20 percent, together with a

(Visited 3 times, 1 visits today)
3
Like
Save

Comments

Write a comment